| Source: |
| Type: |
| BCAP (B-cell adaptor for phosphoinositide 3-kinase) expression has been studied in various types of cancer, particularly in B-cell malignancies. BCAP is primarily expressed in B-cells, and its expression levels can be altered in B-cell malignancies such as chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), and other lymphomas. BCAP is involved in the PI3K signaling pathway, which is crucial for cell growth, survival, and metabolism. Some studies suggest that BCAP may be involved in the signaling pathways that affect tumor growth and metastasis. High BCAP expression could correlate with poor prognosis in certain subtypes of breast cancer. |
| 227- | MFrot, | MF, | Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway |
| - | in-vivo, | Lung, | A549 | - | in-vitro, | Lung, | A549 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:583 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid